Emergent BioSolutions Cash Conversion Cycle 2011-2026 | EBS

Annual Cash Conversion Cycle Emergent BioSolutions

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008
360	186	181	193	147	160	198	268	284	220	180	125	1.65	-3.46	-112	25.1	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
360	-112	151

Quarterly Cash Conversion Cycle Emergent BioSolutions

2026-Q1	2025-Q3	2025-Q2	2025-Q1	2024-Q3	2024-Q2	2024-Q1	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	-	-	-	-	-	189	-	-	-	168	-	67.7	-	71.6	151	255	36.1	159	174	296	68.5	187	217	253	88.5	303	243	347	67.7	295	396	110	83.3	88.4	138	112	65	67.6	87.4	129	36.3	38.9	48.7	101	56.4	62	67.1	166	92.6	132	125	154	62.7	115	76.8	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
396	36.1	139

Cash Conversion Cycle of other stocks in the Drug manufacturers industry

Issuer	Cash Conversion Cycle	Price	% 24h	Market Cap	Country
Endo International plc ENDP	141	-	-	$ 28.9 M	Irlanda
Evoke Pharma EVOK	55.1	-	-	$ 36.6 M	USA
Cumberland Pharmaceuticals CPIX	-227	$ 5.6	-1.23 %	$ 83.2 M	USA
HEXO Corp. HEXO	775	-	2.45 %	$ 38.1 M	Canada
AcelRx Pharmaceuticals ACRX	-38	-	7.5 %	$ 6.35 M	USA
DURECT Corporation DRRX	-4.1 K	-	-	$ 50.1 M	USA
Adamis Pharmaceuticals Corporation ADMP	-224	-	0.86 %	$ 117 M	USA
Aerie Pharmaceuticals AERI	460	-	-	$ 754 M	USA
Agile Therapeutics AGRX	-206	-	10.11 %	$ 58.2 M	USA
Alimera Sciences ALIM	-128	-	-	$ 142 M	USA
Cronos Group CRON	61.7	$ 2.68	-2.55 %	$ 1.03 B	Canada
Athenex ATNX	137	-	-23.39 %	$ 1.76 M	USA
Harrow Health HROW	-46.2	$ 37.64	-0.03 %	$ 1.38 B	USA
Avadel Pharmaceuticals plc AVDL	192	-	-	$ 2.06 B	France
Catalent CTLT	110	-	-	$ 11.5 B	USA
Eagle Pharmaceuticals EGRX	139	-	-39.89 %	$ 27.7 M	USA
Canopy Growth Corporation CGC	177	$ 1.0	-0.99 %	$ 108 M	Canada
Organogenesis Holdings ORGO	106	$ 2.34	-1.68 %	$ 297 M	USA
Pacira BioSciences PCRX	209	$ 22.99	-1.58 %	$ 1.06 B	USA
Sonoma Pharmaceuticals SNOA	150	$ 1.09	-0.91 %	$ 1.35 M	USA
Aurora Cannabis ACB	1.45 K	$ 3.04	-1.3 %	$ 167 M	Canada
Jupiter Wellness JUPW	-186	-	-	$ 33.6 M	USA
Lannett Company LCI	173	-	1.15 %	$ 7.11 M	USA
OrganiGram Holdings OGI	2.92 K	$ 1.06	-1.85 %	$ 101 M	Canada
Tilray TLRY	169	$ 4.98	-2.73 %	$ 3.08 B	Canada
cbdMD YCBD	83	$ 0.69	-1.72 %	$ 2.78 M	USA
Evolus EOLS	74.8	$ 6.73	3.38 %	$ 434 M	USA
Veru VERU	19.6	$ 3.0	-7.98 %	$ 43.9 M	USA
Assertio Holdings ASRT	467	$ 23.48	0.04 %	$ 150 M	USA
ProPhase Labs PRPH	136	-	-	$ 5.07 M	USA
Radius Health RDUS	-35	-	-	$ 1.42 B	USA
Bausch Health Companies BHC	79.8	$ 5.06	-1.94 %	$ 1.88 B	Canada
PetIQ PETQ	53.8	-	1.64 %	$ 400 M	USA
Recro Pharma REPH	105	-	-4.76 %	$ 65.3 M	USA
OptiNose OPTN	491	-	-	$ 1.08 B	USA
SCYNEXIS SCYX	2.74	$ 4.23	-0.35 %	$ 211 M	USA
PLx Pharma PLXP	113	-	-27.8 %	$ 2.56 M	USA
Viatris VTRS	150	$ 16.48	1.04 %	$ 19.2 B	USA
Zomedica Corp. ZOM	154	-	-0.21 %	$ 98 M	USA
Zynerba Pharmaceuticals ZYNE	14.6 K	-	-	$ 55.5 M	USA
Rockwell Medical RMTI	57	$ 0.62	0.35 %	$ 22.3 M	USA
China Pharma Holdings CPHI	139	$ 0.71	-6.82 %	$ 3.05 M	China
TherapeuticsMD TXMD	-723	$ 2.2	20.88 %	$ 25.5 M	USA